[South Africa] Aspen Pharmacare lists on A2X

Specialty and branded multinational pharmaceutical company, Aspen Pharmacare Holdings (share code: APN) shares become available for trade on A2X Markets today. 

Aspen will retain its primary listing on the JSE and its issued share capital will be unaffected by its secondary listing on A2X. 

Stephen Saad, Aspen Group Chief Executive said, “We continually strive to identify ways to increase value for our shareholders and the complementary A2X listing offers investors trading benefits while simultaneously providing the prospect of increasing our shareholder base.” 

A2X CEO, Kevin Brady commented, “We are delighted to have South Africa’s largest pharmaceutical company on board.  This latest listing comes at a time when trading activity levels are increasing sharply on A2X. We look forward to demonstrating the benefits of a secondary listing to Aspen, as our lower fees and narrower spreads attract increasing investor interest.”

Aspen’s listing will bring the number of companies available for trade on A2X to 18 with a combined market capitalisation of over R2.2 trillion. A2X boasts listings from many key sectors, including media, mining, banking, property, FMCG, financial services, insurance and telecommunications. 

A2X is a licensed stock exchange which provides a secondary listing venue for companies. It is regulated by the Financial Sector Conduct Authority and the Prudential Authority (SARB) in terms of the Financial Markets Act. A2X began trading in October 2017 and has nine approved brokers.

www.a2x.co.za